Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy of Adjunctive Infliximab vs Placebo in the Treatment of Adults With Bipolar I/II Depression: A Randomized Clinical Trial.
McIntyre RS, Subramaniapillai M, Lee Y, Pan Z, Carmona NE, Shekotikhina M, Rosenblat JD, Brietzke E, Soczynska JK, Cosgrove VE, Miller S, Fischer EG, Kramer NE, Dunlap K, Suppes T, Mansur RB. McIntyre RS, et al. Among authors: kramer ne. JAMA Psychiatry. 2019 Aug 1;76(8):783-790. doi: 10.1001/jamapsychiatry.2019.0779. JAMA Psychiatry. 2019. PMID: 31066887 Free PMC article. Clinical Trial.
Extracellular Vesicle Biomarkers Reveal Inhibition of Neuroinflammation by Infliximab in Association with Antidepressant Response in Adults with Bipolar Depression.
Mansur RB, Delgado-Peraza F, Subramaniapillai M, Lee Y, Iacobucci M, Rodrigues N, Rosenblat JD, Brietzke E, Cosgrove VE, Kramer NE, Suppes T, Raison CL, Chawla S, Nogueras-Ortiz C, McIntyre RS, Kapogiannis D. Mansur RB, et al. Among authors: kramer ne. Cells. 2020 Apr 6;9(4):895. doi: 10.3390/cells9040895. Cells. 2020. PMID: 32268604 Free PMC article. Clinical Trial.
Leptin mediates improvements in cognitive function following treatment with infliximab in adults with bipolar depression.
Mansur RB, Subramaniapillai M, Lee Y, Pan Z, Carmona NE, Shekotikhina M, Iacobucci M, Rodrigues N, Nasri F, Rashidian H, Rosenblat JD, Brietzke E, Cosgrove VE, Kramer NE, Suppes T, McIntyre RS. Mansur RB, et al. Among authors: kramer ne. Psychoneuroendocrinology. 2020 Oct;120:104779. doi: 10.1016/j.psyneuen.2020.104779. Epub 2020 Jun 20. Psychoneuroendocrinology. 2020. PMID: 32603956
Effects of infliximab on brain neurochemistry of adults with bipolar depression.
Mansur RB, Subramaniapillai M, Lee Y, Pan Z, Carmona NE, Shekotikhina M, Iacobucci M, Rodrigues N, Nasri F, Rosenblat JD, Brietzke E, Cosgrove VE, Kramer NE, Suppes T, Newport J, Hajek T, McIntyre RS. Mansur RB, et al. Among authors: kramer ne. J Affect Disord. 2021 Feb 15;281:61-66. doi: 10.1016/j.jad.2020.11.128. Epub 2020 Dec 3. J Affect Disord. 2021. PMID: 33296798 Clinical Trial.
Exploring brain insulin resistance in adults with bipolar depression using extracellular vesicles of neuronal origin.
Mansur RB, Delgado-Peraza F, Subramaniapillai M, Lee Y, Iacobucci M, Nasri F, Rodrigues N, Rosenblat JD, Brietzke E, Cosgrove VE, Kramer NE, Suppes T, Raison CL, Fagiolini A, Rasgon N, Chawla S, Nogueras-Ortiz C, Kapogiannis D, McIntyre RS. Mansur RB, et al. Among authors: kramer ne. J Psychiatr Res. 2021 Jan;133:82-92. doi: 10.1016/j.jpsychires.2020.12.007. Epub 2020 Dec 4. J Psychiatr Res. 2021. PMID: 33316649 Free PMC article. Clinical Trial.
Peripheral inflammatory biomarkers define biotypes of bipolar depression.
Lee Y, Mansur RB, Brietzke E, Kapogiannis D, Delgado-Peraza F, Boutilier JJ, Chan TCY, Carmona NE, Rosenblat JD, Lee J, Maletic V, Vinberg M, Suppes T, Goldstein BI, Ravindran AV, Taylor VH, Chawla S, Nogueras-Ortiz C, Cosgrove VE, Kramer NE, Ho R, Raison CA, McIntyre RS. Lee Y, et al. Among authors: kramer ne. Mol Psychiatry. 2021 Jul;26(7):3395-3406. doi: 10.1038/s41380-021-01051-y. Epub 2021 Mar 3. Mol Psychiatry. 2021. PMID: 33658605 Free PMC article. Clinical Trial.
Association of ERBB Mutations With Clinical Outcomes of Afatinib- or Erlotinib-Treated Patients With Lung Squamous Cell Carcinoma: Secondary Analysis of the LUX-Lung 8 Randomized Clinical Trial.
Goss GD, Felip E, Cobo M, Lu S, Syrigos K, Lee KH, Göker E, Georgoulias V, Li W, Guclu S, Isla D, Min YJ, Morabito A, Ardizzoni A, Gadgeel SM, Fülöp A, Bühnemann C, Gibson N, Krämer N, Solca F, Cseh A, Ehrnrooth E, Soria JC. Goss GD, et al. JAMA Oncol. 2018 Sep 1;4(9):1189-1197. doi: 10.1001/jamaoncol.2018.0775. JAMA Oncol. 2018. PMID: 29902295 Free PMC article. Clinical Trial.
Evaluation of the VeriStrat® serum protein test in patients with advanced squamous cell carcinoma of the lung treated with second-line afatinib or erlotinib in the phase III LUX-Lung 8 study.
Gadgeel S, Goss G, Soria JC, Felip E, Georgoulias V, Lu S, Cobo M, Syrigos K, Lee KH, Göker E, Guclu SZ, Isla D, Morabito A, Dupuis N, Bühnemann C, Krämer N, Solca F, Ehrnrooth E, Ardizzoni A. Gadgeel S, et al. Lung Cancer. 2017 Jul;109:101-108. doi: 10.1016/j.lungcan.2017.05.010. Epub 2017 May 11. Lung Cancer. 2017. PMID: 28577938 Free article. Clinical Trial.
42 results